DSpace

DSpace at RU >

Browsing by Author Amant, F.

Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 10 of 10
Full TextIssue DateTitleAuthor(s)
2011Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumAmankwah, E.K.; Wang, Q.; Schildkraut, J.M.; Tsai, Y.Y.; Ramus, S.J., et al
2010Breast cancer in pregnancy: recommendations of an international consensus meeting.Amant, F.; Deckers, S.; Calsteren, K. van; Loibl, S.; Halaska, M., et al
2010Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study.Calsteren, K. van; Verbesselt, R.; Ottevanger, N.; Halaska, M.; Heyns, L., et al
2010A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Goode, E.L.; Chenevix-Trench, G.; Song, H.; Ramus, S.J.; Notaridou, M., et al
2010Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes.Calsteren, K. van; Heyns, L.; Smet, F. De; Eycken, L. Van; Gziri, M.M., et al
2010Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.Vergote, I.; Trope, C.G.; Amant, F.; Kristensen, G.B.; Ehlen, T., et al
2009Gynecologic cancers in pregnancy: guidelines of an international consensus meeting.Amant, F.; Calsteren, K. van; Halaska, M.J.; Beijnen, J.H.; Lagae, L., et al
2008Gynecologic oncology in pregnancy.Amant, F.; Calsteren, K Van; Vergote, I.; Ottevanger, N.
2004Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.Amant, F.; Steenkiste, E.; Schuurmans, K.; Verbist, L.; Abeler, V.M., et al
2004Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.Amant, F.; Schuurmans, K.; Steenkiste, E.; Verbist, L.; Abeler, V.M., et al
Showing results 1 to 10 of 10

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback